68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake
Molecules · 2023
DOI: 10.3390/molecules28041977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Lei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 1L3, Canada. Hauptthemen laut MEDLINE: Bombesin, Receptors, Bombesin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, China Scholarship Council.
Abstract (Originalsprache)
With overexpression in various cancers, the gastrin-releasing peptide receptor (GRPR) is a promising target for cancer imaging and therapy. However, the high pancreas uptake of reported GRPR-targeting radioligands limits their clinical application. Our goal was to develop 68Ga-labeled agonist tracers for detecting GRPR-expressing tumors with positron emission tomography (PET), and compare them with the clinically validated agonist PET tracer, [68Ga]Ga-AMBA. Ga-TacBOMB2, TacBOMB3, and TacBOMB4, derived from [Thz14]Bombesin(7–14), were confirmed to be GRPR agonists by a calcium mobilization study, and their binding affinities (Ki(GRPR)) were determined to be 7.62 ± 0.19, 6.02 ± 0.59, and 590 ± 36.5 nM, respectively, via in vitro competition binding assays. [68Ga]Ga-TacBOMB2, [68Ga]Ga-TacBOMB3, and [68Ga]Ga-AMBA clearly visualized PC-3 tumor xenografts in a PET imaging study. [68Ga]Ga-TacBOMB2 showed comparable tumor uptake but superior tumor-to-background contrast ratios when compared to [68Ga]Ga-AMBA. Moreover, [68Ga]Ga-TacBOMB2 and [68Ga]Ga-TacBOMB3 showed a much lower rate of uptake in the pancreas (1.30 ± 0.14 and 2.41 ± 0.72%ID/g, respectively) than [68Ga]Ga-AMBA (62.4 ± 4.26%ID/g). In conclusion, replacing Met14 in the GRPR-targeting sequence with Thz14 retains high GRPR-binding affinity and agonist properties. With good tumor uptake and tumor-to-background uptake ratios, [68Ga]Ga-TacBOMB2 is promising for detecting GRPR-expressing tumors. The much lower pancreas uptake of [68Ga]Ga-TacBOMB2 and [68Ga]Ga-TacBOMB3 suggests that [Thz14]Bombesin(7–14) is a promising targeting vector for the design of GRPR-targeting radiopharmaceuticals, especially for radioligand therapy application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 1L3, Canada.
- Department of Radiology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
- Department of Functional Imaging, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
ORCID-Profile: Ruiyan Tan, Kuo-Shyan Lin
Förderung
- Canadian Institutes of Health Research
- China Scholarship Council
Zitieren
APA
Wang, L., Bratanovic, I. J., Zhang, Z., Kuo, H. T., Merkens, H., Zeisler, J., Zhang, C., Tan, R., Bénard, F., & Lin, K. S. (2023). 68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake. Molecules. https://doi.org/10.3390/molecules28041977
Vancouver
Wang L, Bratanovic IJ, Zhang Z, Kuo HT, Merkens H, Zeisler J, et al. 68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake. Molecules. 2023. doi:10.3390/molecules28041977
BibTeX
@article{Wang2023,
author = {Wang, Lei and Bratanovic, Ivica Jerolim and Zhang, Zhengxing and Kuo, Hsiou-Ting and Merkens, Helen and Zeisler, Jutta and Zhang, Chengcheng and Tan, Ruiyan and Bénard, François and Lin, Kuo-Shyan},
title = {68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28041977}
}
EUVIMED